Sort   by:  
 Page size 
UnknownCytotoxic T-lymphocyte infiltration and chemokine predict long-term patient survival independently of tumor mutational burden in triple-negative breast cancer.
Not available
S-EPMC8024454 | biostudies-literature
UnknownThe 3' untranslated region of sindbis virus represses deadenylation of viral transcripts in mosquito and Mammalian cells.
Not available
S-EPMC2224598 | biostudies-literature
UnknownIncreased PIEZO1 Expression Is Associated with Worse Clinical Outcomes in Hormone-Receptor-Negative Breast Cancer Patients.
Not available
S-EPMC10887014 | biostudies-literature
UnknownPrognostic Significance of Stromal Versus Intratumoral Infiltrating Lymphocytes in Different Subtypes of Breast Cancer Treated With Cytotoxic Neoadjuvant Chemotherapy.
Not available
S-EPMC5550367 | biostudies-literature
UnknownContribution of Immune Cells to Glucocorticoid Receptor Expression in Breast Cancer.
Not available
S-EPMC7370149 | biostudies-literature
UnknownHigh MYC mRNA Expression Is More Clinically Relevant than MYC DNA Amplification in Triple-Negative Breast Cancer.
Not available
S-EPMC6981812 | biostudies-literature
UnknownClinical Trials with Oncolytic Measles Virus: Current Status and Future Prospects.
Not available
S-EPMC5630504 | biostudies-literature
UnknownRecruitment of Intratumoral CD103+ Dendritic Cells by a CXCR4 Antagonist-Armed Virotherapy Enhances Antitumor Immunity.
Not available
S-EPMC6667789 | biostudies-literature
UnknownSystemic Therapy De-Escalation in Early-Stage Triple-Negative Breast Cancer: Dawn of a New Era?
Not available
S-EPMC9025008 | biostudies-literature
UnknownMechano-Sensing Channel PIEZO2 Enhances Invasive Phenotype in Triple-Negative Breast Cancer.
Not available
S-EPMC9455988 | biostudies-literature
Sort   by:  
 Page size